Company Search:
Advanced Search
Sponsored Links
Parenteral Drugs (India) Limited Company Snapshot
Parenteral Drugs (India) Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Parenteral Drugs (India) Limited with three other companies in this sector in India: Themis Medicare Limited (2017 sales of 2.46 billion Indian Rupees [US$37.83 million] ), Bal Pharma Limited (2.29 billion Indian Rupees [US$35.23 million] ), and SMS Lifesciences India Ltd (2.16 billion Indian Rupees [US$33.23 million] ).

Sales Analysis. Parenteral Drugs (India) Limited reported sales of 2.30 billion Indian Rupees (US$35.36 million) for the fiscal year ending March of 2017. This represents a decrease of 11.7% versus 2016, when the company's sales were 2.60 billion Indian Rupees.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Parenteral Drugs (India) Limited
  Stock Performance Chart for Parenteral Drugs (India) Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 17.55
(Figures in Indian Rupees)
1 Week -2.5%   13 Weeks -13.3%  
4 Weeks -2.0%   52 Weeks -35.2%  
Parenteral Drugs (India) Limited Key Data:
  Ticker: PDPL Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 2,297,394,804
(Year Ending Jan 2018).
Employees: N/A
  Currency: Indian Rupees Market Cap: 523,276,065
  Fiscal Yr Ends: March Shares Outstanding: 29,816,300
  Share Type: Ordinary Closely Held Shares: 22,859,307
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.